MonashCID

ImmuMon is back for 2026! 🗓️ 11th September 📍 Alfred Research Alliance, Innovation & Education Hub We are currently seeking sponsors, please contact us at immumon@monash.edu to get involved.

Glad to share our recent paper exploring self management strategies in #lupus patients - we need tailored education that promotes patient activation. @SCSMonash sciencedirect.com:5037/science/articl…

Congratulations to Professors Graeme Polglase and Connie Wong, awarded 2025 @heartfoundation grants for innovative research in newborn resuscitation and stroke-related inflammation. Their work continues to advance cardiovascular health across the lifespan. 🔗 Read more: bit.ly/3LD1CjM #HeartFoundation #Research #CardiovascularHealth #Monash

Last chance everyone! Submit your abstract and join the over 55 invited international speakers at the Workshop #vasculitismelbourne2026 Case reports and case series are welcome And remember the new Young Invstigator Award Session. See you in 2026!

Proud to share @ZhiLim8's latest review on promising new treatments for #Sjogrens! 🧬 How engineered regulatory T cell therapies could help rebalance the immune system and bring relief to patients? @OoiLabs @alberta_hoi @MonashCID @SCSMonash @MonashHealth sciencedirect.com/science/articl…

New @SCSMonash research led by @cwonglab and Dr Joshua Bourne shows microglia, not invading immune cells, drive damaging inflammation in the first hours after stroke. Targeting these brain-resident cells could protect function and improve recovery. Read more 👉 monash.edu/medicine/news/… #StrokeResearch @MonashUni @Monash_FMNHS

@SCSMonash Monash University/Monash Health is making important advances against Sjögren’s disease in Australia, through establishment of Monash Sjögren Registry. See more about the disease insightplus.mja.com.au/2025/33/sjogre…

Fabulous collaboration between @SCSMonash @MonashCID @Hudson_Research and A/Prof Grant Logan from @CMRI_AUS harnessing gene therapy to deliver therapeutic doses of DNaseI to clear extracellular DNA release from NETs in experimental ANCA Vasculitis.

Extracellular DNA is known to induce inflammation, but does it drive kidney damage in autoimmune vasculitis? @Kim_M_OS & team @MonashUni report on targeting ecDNA with DNAase I in models of MPO-ANCA vasculitis. See full report: insight.jci.org/articles/view/…

2 WEEKS TO GO! Abstract submissions for #ImmuMon2025 close in just TWO WEEKS! Don’t miss your chance to share your latest immunology research with researchers across Monash University. Abstract Deadline: 15th August Submit now: immumon.com/registration-a…

Congrats to Prof Richard Kitching on the 2025 APSN Award for Excellence in Basic Science 👏 A leader in autoimmune kidney research at @MonashUni and @MonashHealth, and co-founder of ANZVASC. Read more: bit.ly/4nONbYF #Nephrology #Vasculitis #KidneyResearch #ClinicalSciences #MonashHealth #MonashUniversity

Time is critical in AAV: dampening kidney inflammation prevents damage Why not target effector T cells - leave other T cells alone? Our paper in @NDTSocial defines IL-7Ra as a target doi.org/10.1093/ndt/gf… Anti-IL-7Ra Abs are in Phase 2 trials - alopecia @Q32Bio ?an AAV therapy

Proud to share this work led by @cpelkas highlighting exciting new treatment developments for #Sjogrens—alongside a concerning lack of diversity in clinical trials. Greater inclusivity is essential @MonashCID @SCSMonash @UniofAdelaide @TQEHofficial sciencedirect.com/science/articl…

Big congratulations to our newly promoted academic leaders at @SCSMonash! 👏 Professors @alberta_hoi, @DrKPalmer and @cwonglab 👏 Associate Professors @DrAyseZ, @PFaridi, @SimonAJoosten1, Nicole Kellow, Mary-Ann Davey and Calum Roberts. We’re proud to celebrate an all-woman cohort of Level E promotions this year, a milestone for equity in academic leadership. #ClinicalSciences #MonashHealth #AcademicExcellence #WomenInSTEM #STEMLeadership #PromotionCelebration

Delighted to share this collaborative work published in Best Prac Res and Clinical #rheumatology highlighting the latest therapeutic advances and assessing clinical trial inclusivity in #Sjogrens @MonashCID @SCSMonash @cpelkas @UniofAdelaide @TQEHofficial sciencedirect.com/science/articl…

IL-7Ra signalling in AAV links to relapse/resistance Our recent paper 🔹defined activated & exhausted T cells in experimental AAV kidneys 🔹neutralised IL-7Ra - a non-depleting mAb - to limit ANCA-associated GN Similar mAbs are in Phase 2 clinical trials academic.oup.com/ndt/article-ab…

🚨 Registration and abstract submission for Immumon 2025 is OPEN! ✨ 🔗 Download the abstract template and submit before August 15th immumon.com/abstractinstru… 👉 FREE registration at immumon.com/registration-a… 𝦩👋 See you at the BDI ⭐️

New study in @Lupus_SM from researchers at @SCSMonash and @Hudson_Research shows we're missing crucial testing opportunities for #lupus patients: -1/3 of lupus patients should be tested for #primaryaldosteronism -Only 3% actually receive this simple blood test -Could reduce hypertension & CV disease risk. Read more here ➡️: monash.edu/medicine/news/… @DrJunYang @FabOzy @Monash_FMNHS @MonashHealth

Let's look deeply at this #OpenAccess #ArticleinPress from @Monash_FMNHS, Looking below the surface - using intravital imaging to decipher inflammatory renal disease and renal cell injury (M. J. Hickey and V. Sudhakar): ow.ly/rRS550V306i #Imaging #Injury #Disease

CV red flag missed in #Lupus patients rheuma.com.au/cv-red-flag-mi… #PrimaryAldosteronism @DrJunYang @alberta_hoi @Lupus_SM @MonashCID @SCSMonash @CEM_Hudson @Hudson_Research @MonashHealth